Skip to main content
. 2015 Mar 12;11(3):e1004655. doi: 10.1371/journal.ppat.1004655

Fig 3. Urine neopterin concentrations at enrollment in the 4 clinical groups.

Fig 3

A: Comparison of total urine neopterins, dihydroneopterin plus neopterin (NH2 + N0), concentrations at enrollment for healthy controls (HC, n = 111), uncomplicated malaria (UM, n = 55), cerebral malaria (CM, n = 45) and non-malaria central nervous system conditions (NMC, n = 48) (p<0.001 by Kruskal-Wallis). The central line indicates median. Upper and lower lines indicate inter-quartile range. B: Comparison of urine dihydroneopterin to neopterin (NH2:N0) at enrollment for all 4 groups (p = 0.018 by Kruskal-Wallis). The number of subjects with a sample measured is the same as noted above in [A]. The central line indicates median. Upper and lower lines indicate inter-quartile range.